Clearside Biomedical, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Clearside Biomedical, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2023.
  • Clearside Biomedical, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$7.59M, a 16.6% increase year-over-year.
  • Clearside Biomedical, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$33.5M, a 6.75% increase year-over-year.
  • Clearside Biomedical, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$32.5M, a 1.4% increase from 2022.
  • Clearside Biomedical, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$32.9M, a 8863% decline from 2021.
  • Clearside Biomedical, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $376K.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$32.5M +$462K +1.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 -$32.9M -$33.3M -8863% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 $376K +$18.6M Jan 1, 2021 Dec 31, 2021 10-K 2024-03-12
2020 -$18.2M +$12.6M +40.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-14
2019 -$30.8M +$52M +62.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
2018 -$82.8M -$23.8M -40.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
2017 -$59M -$33.1M -128% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-13
2016 -$25.9M -$8.24M -46.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
2015 -$17.6M -$7.45M -73.1% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2014 -$10.2M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.